Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3TYP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,817
Award facts
- Contract value 100% obligated
- $16,816.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,816.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on January 20, 2026, with an ultimate completion date of January 21, 2026. This non-competitive delivery order was placed against AmerisourceBergen's parent company, Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, medical supplies, specialty medications, brand-name and generic drugs, and vaccines to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's fulfillment of this diabetes medication order represents routine pharmaceutical procurement through the established DLA Troop Support Medical contract vehicle, which continues to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order demonstrates AmerisourceBergen's role as a primary pharmaceutical distributor across multiple therapeutic domains for federal medical supply requirements.
Quick answers
Who was awarded contract SPE2DR26F3TYP?
SPE2DR26F3TYP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F3TYP worth?
The government has obligated $16,817 on SPE2DR26F3TYP.
Is contract SPE2DR26F3TYP an order under another contract?
Yes. SPE2DR26F3TYP is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TYP competed?
The extent of competition for SPE2DR26F3TYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award